![Sergey Yurasov](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sergey Yurasov
Hoofd Techniek/Wetenschap/O&O bij
BLACK DIAMOND THERAPEUTICS, INC.
Vermogen: 40 699 $ op 31-07-2026
Profiel
Sergey Yurasov currently works at Black Diamond Therapeutics, Inc., as Chief Medical Officer from 2022.
Dr. Yurasov also formerly worked at Hoffman-La Roche, Inc., as Clinical Director-Oncology & Pharma Research, ImClone LLC, as Associate Vice President-Global Medicine Science, The Rockefeller University, as Assistant Professor-Clinical Investigation, Immune Design Corp., as Chief Medical Officer & SVP-Clinical Development from 2016 to 2019, Clovis Oncology, Inc., as Senior Vice President-Clinical Development in 2016, and Nuvation Bio, Inc., as Chief Medical Officer from 2019 to 2022.
Dr. Yurasov received his doctorate degree from Russian State Medical University and doctorate degree from Research Institute for Pediatric Oncology.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 27-04-2026 | 24.082 ( 0,04% ) | 40 699 $ | 31-07-2026 |
Actieve functies van Sergey Yurasov
| Bedrijven | Functie | Begin |
|---|---|---|
| BLACK DIAMOND THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-06-2022 |
Eerdere bekende functies van Sergey Yurasov
| Bedrijven | Functie | Einde |
|---|---|---|
| NUVATION BIO INC. | Hoofd Techniek/Wetenschap/O&O | 01-02-2022 |
| IMMUNE DESIGN CORP | Hoofd Techniek/Wetenschap/O&O | 02-04-2019 |
| CLOVIS ONCOLOGY, INC. | Corporate Officer/Principal | 01-09-2016 |
The Rockefeller University
 The Rockefeller University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Hoffman-La Roche, Inc.
 Hoffman-La Roche, Inc. Pharmaceuticals: MajorHealth Technology Researches, develops and manufactures medicines, diagnostics and vitamins | Corporate Officer/Principal | - |
Opleiding van Sergey Yurasov
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
53
Eerstegraads connecties
9
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 9 |
|---|---|
ImClone LLC
 ImClone LLC BiotechnologyHealth Technology Develops novel therapeutic products and blood cell growth factors for the treatment of cancer | Health Technology |
The Rockefeller University
The Rockefeller University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Immune Design Corp.
 Immune Design Corp. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical and clinical-stage immunotherapy company | Health Technology |
Russian State Medical University
 Russian State Medical University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Clovis Oncology, Inc.
 Clovis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Operates as an biopharmaceutical company that acquires, develops and commercializes innovative anti cancer agents | Health Technology |
Hoffman-La Roche, Inc.
Hoffman-La Roche, Inc. Pharmaceuticals: MajorHealth Technology Researches, develops and manufactures medicines, diagnostics and vitamins | Health Technology |
Research Institute for Pediatric Oncology
 Research Institute for Pediatric Oncology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Black Diamond Therapeutics, Inc.
 Black Diamond Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops precision medicines for cancer | Health Technology |
Nuvation Bio, Inc.
 Nuvation Bio, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company which develops oncology related novel therapeutic candidates | Health Technology |
